CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 4 Open-market buy SVP, General Counsel bought 10,000 shares at $4.07 ($40,747)
- 4 Open-market buy SVP-Bus. Process & Info. Tech. bought 600 shares at $3.81 ($2,286)
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Unregistered share sale · Other events
- 4 Shares withheld for taxes CEO and President gave up 154 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 149 shares (to pay taxes)
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 6,591 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 6,780 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- DEFA14A Proxy Proxy Materials
Page 29 of 35 · 690 filings